Glaukos Corporation
medical technology company
Based in CA
🤖
AI Overview
With $680K in lobbying spend across 24 quarterly filings, Glaukos Corporation is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$680K
Total Spend
6
Years Active
1
Firms Hired
5
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $0 |
| 2021 | $110K |
| 2024 | $90K |
| 2025 | $80K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Health Issues, Medicare/Medicaid, Taxation
- •Issues related to medical technology used for the treatment of glaucoma, including issues related to Medicare reimbursement for certain surgical procedures.
- •Issues related to implementation of the 21st Century Cures Act (P.L.114-255).
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.